Ocfentanil is a potent synthetic opioid structurally related to fentanyl that was developed in the early 1990s as one of a series of potent naloxone-reversible opioids. The aim was to obtain an opioid with better therapeutic indices regarding cardiovascular effects and respiratory depression compared to fentanyl. Despite showing reasonable results in human clinical trials, Ocfentanil was never developed for medical use. However, it subsequently began to be sold as a designer drug around 2013.
Okfentaníl molecular structure diagram from the DrugsPRO substance library.
Also known as: N-(2-fluorophenyl)-2-methoxy-N-[1-(2-phenylethyl)-4-piperidinyl] acetamide
Classification
Chemical: Anilidopiperidine
Chemical: Medicine
Chemical: Opioid
Psychoactive: Depressant
Effects
Sedation
Motor Impairment
Respiratory Depression
Constipation
Pupil Constriction
Itchiness
Reduced Anxiety
Euphoria
Anxiety Suppression
Dulled Perception
Routes of Administration
No route information available yet.
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
This static page is intended as a readable non-JS and prerender-friendly library export.
Get the full DrugsPRO experience
Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.
Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu
Ocfentanil - DrugsPRO efnisleiðsögn
Ocfentanil: Ocfentanil is a potent synthetic opioid structurally related to fentanyl that was developed in the early 1990s as one of a series of potent naloxone-reversible opioids. The aim was to obtain an opioid with better therapeutic indices regarding cardiovascular effects and respiratory depres
